Januvia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Conditions:   Immune Thrombocytopenia;   Blood Coagulation Disorders;   Thrombocytopenia;   Physiological Effects of Drugs Interventions:   Drug: Sitagliptin;   Drug: Danazol Sponsor:   Peking University People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials